What Does PharmaMar Do?

Total employees647
HeadquartersColmenar Viejo
Founded1986

PharmaMar is a Spanish biopharmaceutical company headquartered in Madrid, specializing in the research, development, and commercialization of novel anti-tumor drugs of marine origin. With a strong focus on oncology, PharmaMar has successfully brought to market treatments like Yondelis® (trabectedin) for soft tissue sarcoma and ovarian cancer, and Zepzelca® (lurbinectedin) for metastatic small cell lung cancer. The company's unique approach leverages the biodiversity of the ocean to identify and develop compounds with therapeutic potential, managing an extensive marine organism library. PharmaMar has a robust pipeline of drug candidates and strategic partnerships to expand its reach globally.

Where Is PharmaMar's Headquarters?

HQ Function

The headquarters serves as the primary center for PharmaMar's global operations, including cutting-edge research and development in marine-derived compounds, drug discovery, preclinical and clinical development, corporate strategy, and administrative functions.

Notable Features:

The facility houses state-of-the-art laboratories for molecular biology, cell culture, chemical synthesis, and pharmacology. It also includes specialized infrastructure for the collection, identification, and analysis of marine organisms, forming the core of their unique drug discovery platform.

Work Culture:

PharmaMar fosters a highly scientific and innovative work environment, encouraging collaboration among multidisciplinary teams of biologists, chemists, pharmacologists, and clinicians. There's a strong emphasis on research excellence and a shared mission to combat cancer.

HQ Significance:

This location is pivotal as it underpins PharmaMar's entire value chain, from the initial discovery of active compounds in marine organisms to the advanced stages of drug development and coordination of global commercialization efforts.

Values Reflected in HQ: The headquarters embodies PharmaMar's core values of innovation (through its unique marine research), scientific rigor (advanced R&D facilities), and commitment to patients (focus on developing life-saving oncology drugs).

Location:

PharmaMar supports its global operations through a network of subsidiaries and strategic partnerships. Core functions like research and development are centralized in Spain, while commercialization, medical affairs, and clinical trial management are conducted through its offices in key markets like the USA, Italy, France, Germany, UK, Switzerland, Austria, Belgium and Portugal. Additionally, PharmaMar collaborates with partners to market its products in regions where it doesn't have a direct presence, ensuring broader patient access to its innovative marine-derived oncology treatments worldwide.

Street Address:

Avda. de los Reyes, 1, PolĂ­gono Industrial La Mina-Norte

City:

Colmenar Viejo

State/Province:

Madrid

Country:

Spain

Where Else Does PharmaMar Operate Around the World?

New York, NY, USA

Address: PharmaMar USA Inc., 510 Madison Avenue, Suite 405, New York, NY 10022

To expand market access and drive sales of PharmaMar's oncology drugs in the significant US market, manage relationships with key opinion leaders and healthcare providers, and support ongoing clinical development programs in the region.

Milan, Italy

Address: PharmaMar S.r.l., Via G. Spadolini 7 - Centro Leoni, Edificio B - 4° Piano, 20141 Milan

To ensure successful commercialization and patient access to PharmaMar's therapies in Italy, engaging with local healthcare systems, regulatory bodies, and medical professionals.

Paris, France

Address: PharmaMar SAS, 48 Boulevard des Batignolles, 75017 Paris

To strengthen PharmaMar's presence in France, facilitate access to its innovative cancer treatments, and support local clinical research initiatives.

Buying Intent Signals for PharmaMar

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading PharmaMar? Meet the Executive Team

As of April 2025, PharmaMar' leadership includes:

José María Fernández Sousa-Faro - President and CEO
Luis Mora - Managing Director, General Manager of Oncology & Virology Business Units
MarĂ­a Luisa de Francia - Chief Financial Officer
Pascal Besman - Chief Operating Officer, PharmaMar U.S.A., Inc.
Carmen Cuevas - Director of R&D
Jose Luis Moreno - Director of Capital Markets & Investor Relations

Who's Investing in PharmaMar?

PharmaMar has been backed by several prominent investors over the years, including:

José María Fernández Sousa-Faro (significant individual shareholder)
Rosp Corunna Participaciones Empresariales, S.L.U. (Sandra Ortega Mera's investment vehicle)
Various institutional investors and mutual funds (e.g., Norges Bank Investment Management, The Vanguard Group, BlackRock)

What Leadership Changes Has PharmaMar Seen Recently?

Hire1
Exits0

PharmaMar has seen some key appointments and transitions in its leadership, particularly strengthening its US operations. The core C-suite team in Spain has remained largely stable.

New Appointments:

Dr. Alison Armour, Dr. Alison Armour appointed as Chief Medical Officer for PharmaMar's US operations to bolster medical and clinical leadership in this key market.

What Technology (Tech Stack) Is Used byPharmaMar?

Discover the tools PharmaMar uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

PharmaMar Email Formats and Examples

PharmaMar typically utilizes standard corporate email formats. The most common patterns involve combinations of the employee's first name, last name, or initials followed by '@pharmamar.com'.

[first_initial][last]@pharmamar.com (e.g., jsmith@pharmamar.com) or [first].[last]@pharmamar.com (e.g., john.smith@pharmamar.com)

Format

asmith@pharmamar.com

Example

80%

Success rate

What's the Latest News About PharmaMar?

PharmaMar Official Website / Press Release • May 28, 2024

PharmaMar presents new data on Zepzelca® (lurbinectedin) at ASCO 2024

PharmaMar presented new data on Zepzelca® (lurbinectedin) for the treatment of small cell lung cancer (SCLC) during the American Society of Clinical Oncology (ASCO) Annual Meeting. The presentations included results from a retrospective observational study and a Phase I/II trial in combination therapy....more

PharmaMar Official Website / Press Release • April 26, 2024

PharmaMar reports total revenues of €35.1 million in the first quarter of 2024

PharmaMar reported total revenues of €35.1 million in Q1 2024, with a net profit of €0.2 million. Recurring revenues, including net sales of goods and royalties, were €26.9 million, a decrease attributed to lower Zepzelca® sales in the US compared to the previous year....more

PharmaMar Official Website / Press Release • March 1, 2024

PharmaMar reports a net profit of €1.1 million in 2023

PharmaMar announced a net profit of €1.1 million for the full year 2023, with total revenues reaching €157.7 million. The company highlighted its R&D investment of €61.5 million and progress in its clinical pipeline....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including PharmaMar, are just a search away.